Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
1996-9-25
|
pubmed:abstractText |
Luminol-dependent chemiluminescence (CL) was used to assay the effect of three antituberculous drugs [isoniazid (INH), pyrazinamide (PZA), rifampicin (RM)] on the production of reactive oxygen species (ROS) by polymorphonuclear leukocytes (PMN) isolated from blood of 5 healthy donors. Drugs were added directly to the medium in concentrations; INH 5 micrograms/ml, PZA 40 micrograms/ml, RM 7 micrograms/ml. These concentrations correspond to peak serum concentrations after usual doses. RM was found to inhibit FMLP (N-formyl-methionyl-leucyl -phenylalanine)-induced CL response of PMN, PZA did not influence the metabolic activity of neutrophils, and INH stimulated PMN CL.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antitubercular Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Isoniazid,
http://linkedlifedata.com/resource/pubmed/chemical/Pyrazinamide,
http://linkedlifedata.com/resource/pubmed/chemical/Reactive Oxygen Species,
http://linkedlifedata.com/resource/pubmed/chemical/Rifampin
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0015-5500
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
41
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
257-62
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:8714775-Antitubercular Agents,
pubmed-meshheading:8714775-Humans,
pubmed-meshheading:8714775-Isoniazid,
pubmed-meshheading:8714775-Luminescent Measurements,
pubmed-meshheading:8714775-Neutrophils,
pubmed-meshheading:8714775-Pyrazinamide,
pubmed-meshheading:8714775-Reactive Oxygen Species,
pubmed-meshheading:8714775-Rifampin
|
pubmed:year |
1995
|
pubmed:articleTitle |
Effect of antituberculous drugs, isoniazid, pyrazinamide and rifampicin, on chemiluminescence of the human polymorphonuclear leukocytes.
|
pubmed:affiliation |
National Research Institute of Tuberculosis and Lung Diseases, Warsaw, Poland.
|
pubmed:publicationType |
Journal Article
|